Literature DB >> 10438045

Experimental vaccination against Mycoplasma agalactiae using different inactivated vaccines.

S Tola1, D Manunta, S Rocca, A M Rocchigiani, G Idini, P P Angioi, G Leori.   

Abstract

Five sets of vaccines were prepared using Mycoplasma agalactiae washed cultures inactivated with phenol (1), formalin (2), heat-treatment (3), sodium hypochlorite (4) and saponin (5). All sets, except for saponin-vaccine, were adjuvated with aluminium hydroxide. Five groups of six sarda ewes were inoculated twice before pregnancy, once during pregnancy and challenged during the lactation period. Monthly blood samples were taken from the vaccinated sheep and from 12 controls: sera were assayed by immunoblotting, ELISA and growth inhibition tests. Four control sheep were infected by intracanalicular route with pooled mycoplasmas at concentrations of 10(4), 10(5), 10(6) and 10(7) CCU. The challenge involved using infected milk to contaminate the remaining sheep. All the controls and some ewes from groups 2, 3 and 4 developed contagious agalactia. Ewes vaccinated with phenol- and saponin-inactivated mycoplasmas resisted experimental challenge. These results suggest that these two vaccines are effective and that their use could limit the diffusion of M. agalactiae infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438045     DOI: 10.1016/s0264-410x(99)00070-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Mapping antigenic sites of an immunodominant surface lipoprotein of Mycoplasma agalactiae, AvgC, with the use of synthetic peptides.

Authors:  Antonella Santona; Franco Carta; Peppinetta Fraghí; Franco Turrini
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  The liposoluble proteome of Mycoplasma agalactiae: an insight into the minimal protein complement of a bacterial membrane.

Authors:  Carla Cacciotto; Maria Filippa Addis; Daniela Pagnozzi; Bernardo Chessa; Elisabetta Coradduzza; Laura Carcangiu; Sergio Uzzau; Alberto Alberti; Marco Pittau
Journal:  BMC Microbiol       Date:  2010-08-25       Impact factor: 3.605

3.  Mycoplasma gallisepticum inactivated by targeting the hydrophobic domain of the membrane preserves surface lipoproteins and induces a strong immune response.

Authors:  Hazem Atalla; Inna Lysnyansky; Yossef Raviv; Shlomo Rottem
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

4.  Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens.

Authors:  Peipei Wu; Jihu Lu; Lei Feng; Hongzhuan Wu; Xuehua Zhang; Mei Mei; Jibo Hou; Xiufan Liu; Yinghua Tang
Journal:  Front Microbiol       Date:  2017-05-26       Impact factor: 5.640

5.  An experimental vaccine for calf pneumonia caused by Mycoplasma bovis: clinical, cultural, serological and pathological findings.

Authors:  Robin A J Nicholas; Roger D Ayling; Laszlo P Stipkovits
Journal:  Vaccine       Date:  2002-10-04       Impact factor: 3.641

Review 6.  Contagious Agalactia In Sheep And Goats: Current Perspectives.

Authors:  Maryne Jaÿ; Florence Tardy
Journal:  Vet Med (Auckl)       Date:  2019-12-27

Review 7.  Vaccines for Mycoplasma Diseases of Small Ruminants: A Neglected Area of Research.

Authors:  Katarzyna Dudek; Umit Sevimli; Sergio Migliore; Amirreza Jafarizadeh; Guido R Loria; Robin A J Nicholas
Journal:  Pathogens       Date:  2022-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.